期刊文献+

肝细胞生长因子的表达、纯化和基本活性研究 被引量:1

Expression, purification and preliminary activity study of recombinant hepatocyte growth factor prorein in E. coil
原文传递
导出
摘要 目的通过构建肝细胞生长因子(HGF)基因的重组原核表达载体,转化大肠杆菌,制备HGF重组蛋白并初步证实其活性。方法克隆HGF基因插入载体pET-26b(+),构建重组原核表达载体pET-26b(+)-HGF,转化E-coliRosseta(DE3)。IPTG诱导转化菌表达重组蛋白,采用Ni—NTA树脂亲和层析法进行纯化,复性后冷冻干燥。结果HGF基因重组原核表达载体pET.26b(+).HGF构建成功。转化pET-26b(+)-HGF的EcoliRosseta(DE3)以包涵体形式大量表达目的蛋白,占菌体总蛋白的38%,并经Westernblot证实。经Ni—NTA树脂亲和层析法纯化后HGF蛋白纯度约为95%,作用于人非小细胞肺癌细胞系A549细胞发现可促进其增殖、迁徙并抑制凋亡。结论成功构建了HGF基因重组原核表达载体pET-26b(+)-HGF,转化E-coliRosseta(DE3)后成功表达,纯化复性回复重组HGF蛋白结构,经体外实验证实具有生物学活性。 Objective To prepare hepatocyte growth factor(HGF) recombinant protein and con- firm its activity preliminarily according to building HGF gene prokaryotic expression vector and transforming into E. coll. Methods Clone HGF inserted into the vector pET-26b (+) to construct prokaryotic expression vector pET-26b( + ) -HGF and transform into E. coli Rosseta ( DE3 ). The transformed bacteria induced by IPTG was purified through Ni-NTA resin affinity chromatography frozen-drying after renaturation. Results HGF gene recombinant prokaryotic expression vector pET-26b(+)-HGF was constructed success- fully. E. coli Rosseta( DE3 ) which was transformed into pET-26b(+)-HGF expresses the target protein as the form of inclusion bodies, accounting for 38% of the total bacterial proteins, and confirmed by Western blot. HGF protein which was purified by Ni-NTA resin affinity chromatography, has a purity of about 95 %, and can promote proliferation, migration, and inhibition of apoptosis for human non-small cell lung cancer cell line A549 cells after interaction. Conclusion HGF gene recombinant prokaryotic expression vector pET-26b (+) -HGF was constructed and expressed in transformed E. coli Rosseta ( DE3 ) successfully. They resumed their recombinant HGF protein structure after purification and renaturation, and had biological activity con- firmed by in vitro studies.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2012年第11期967-971,共5页 Chinese Journal of Microbiology and Immunology
基金 浙江省医药卫生科技项目(2007A175) 宁波市科技计划(2007C10065,2010A610031)
关键词 肝细胞生长因子 蛋白 重组 纯化 活性 Hepatocyte growth factor Protein Recombinant Purification Activity
  • 相关文献

参考文献9

  • 1Burrus JK, Matheson WD, Hong JS,et al. HepattK'yte growth factor stimulates adenoviral-mediated gene transfer across the apical membrane of evithelial cells. J Gene Med ,2004,6(6) :624-630.
  • 2Jiang WG, Davies G, Martin TA, et al. The polenlial lymphangio- genic effects of hepatocyte growth factor/seatter factor in vitro and in vivo. Int .1 Mol Med.2005,16(4):723-728.
  • 3Kim JG, Sohn SK, Kim DH, et al. Clinical implications of angiogen- ic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma,2005,46( 6 ) :885- 891.
  • 4滑世轩,岑东,赵行,吕建新,涂植光,裴仁治.NK4基因的克隆及其在Raji细胞中的表达[J].中国病理生理杂志,2009,25(5):970-975. 被引量:5
  • 5Forte G,Minieri M,Cossa P,et al. Hepat(wyte growth factor effects on mesenchymal stem ceils : proliferation, migration,and differentia- tion. Stem Cells,2006,24( 1 ) :23-33.
  • 6汪家政 范明.蛋白质技术手册[M].北京:科学出版社,2001..
  • 7Nakanmra T,Sakai K, Nakamura T,et al. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepato1,2011,26 Suppl 1 : 188-202.
  • 8Martin TA,Jiang WG. Hepatocyte growth factor and its receptor signalling complex as targets in cancer therapy. Anticancer Agents Med Chem,2010,10( 1 ) :2-6.
  • 9Li M, Su ZG, Janson JC. In t'itro protein refolding by chromato- graphic procedures. Protein Expr Purif,2004,33 ( 1 ) :1-10.

二级参考文献15

  • 1周光纪,徐海伟,杨丽,唐军,李达兵,屈纪富.小鼠pdx-1基因真核表达载体的构建及其在胚胎干细胞中的表达[J].中国病理生理杂志,2007,23(6):1204-1207. 被引量:2
  • 2Kuba K, Matsumoto K, Date K, et al. HGF/NK4, a four - Kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice [ J ]. Cancer Res, 2000, 60 (23) :6737 - 6743.
  • 3Jiang WG, Hiscox SE, Parr C, et al. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells [ J].Clin Cancer Res, 1999, 5(11) :3695 -3703.
  • 4Kanehira M, Xin H, Hoshino K, et al. Targeted delivery of NK4 to multiple lung tumors by bone marrow - derived mesenchymal stem cells [ J ]. Cancer Gene Ther, 2007, 14( 11 ) :894 -903.
  • 5Hiscox S, Parr C, Nakamura T, et al. Inhibition of HGF/SF induced breast cancer cell motility and invasion by the HGF/SF variant, NK4 [ J ]. Breast Cancer Res Treat, 2000, 59(3) :245 -254.
  • 6Saga Y, Mizukami H, Suzuki M, et al. Expression of HGF/NK4 in ovarian cancer ceils suppresses intraperitoneal dissemination and extends host survival [ J ]. Gene Ther, 2001, 8(19) :1450 - 1455.
  • 7Okasora T, Jo JI, Tabata Y. Augmented anti - tumor therapy through natural targetability of macrophages genetically engineered by NK4 plasmid DNA [J]. Gene Ther, 2008, 15(7) :524 -530.
  • 8Du W, Hattori Y, Yamada T, et al. NK4, an antagonist of hepatoeyte growth factor (HGF), inhibits growth of multiple myeloma ceils: molecular targeting of angiogenic growth factor [J]. Blood, 2007, 109(7) :3042 -3049.
  • 9Zou HY, Li Q, Lee JH, et al. An orally available small - molecule inhibitor of c - Met, PF - 2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms [ J ]. Cancer Res, 2007, 67 (9) :4408 -4417.
  • 10Son G, Hirano T, Seki E, et al. Blockage of HGF/c - Met system by gene therapy (adenovirus -mediated NK4 gene) suppresses hepatocellular carcinoma in mice [ J ]. J Hepatol, 2006, 45 (5) :688 - 695.

共引文献57

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部